NCT04704219 · Interventional trial
Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)
Overall registry status Completed
Phase 2
Conditions Renal Cell Carcinoma
Delaware Valley sites
- Fox Chase Cancer Center ( Site 0011) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory